06.04.2020 | Invited Editorial Commentary
Neuromonitoring: No Longer a Spectator Sport
verfasst von:
Eric S. Rosenthal
Erschienen in:
Neurocritical Care
|
Ausgabe 3/2020
Einloggen, um Zugang zu erhalten
Excerpt
Seizure diagnosis is a fundamentally challenging issue in neurocritical care. The vast majority of seizures detected by electroencephalography (EEG) are nonconvulsive [
1], yet the yield of scalp EEG is limited without concomitant intracranial recordings [
2,
3]. Because these intracranial recordings may not be appropriate or feasible in all patients, a variety of imaging modalities have been promulgated as “electro-radiologic” evidence of diagnosing status epilepticus, including diffusion-weighted or perfusion imaging [
4‐
6]. While these imaging modalities may lack specificity, [F-18] fluorodeoxyglucose positron emission tomography (FDG-PET) hypermetabolism has been a more recent imaging modality demonstrating promise not only because of its spatial information and its temporal response to anesthetic burst suppression [
7], but due to its dose-dependent metabolic association with spike burden [
8]. …